ADHD medication use was associated with a lower risk for emergency department visits for unintentional injuries and traumatic brain injuries in both boys and girls at the population and individual levels.
The mobile application App4Independence may be a feasible solution to improve self-management in patients with schizophrenia spectrum disorders.
The Food and Drug Administration (FDA) has granted Fast Track designation to ecopipam (Emalex Biosciences), an investigational agent for the treatment of Tourette syndrome (TS).
A review of research reveals that a while ketogenic diet may hold some promise for individuals with mental health disorders, additional studies are necessary.
Researchers assessed the impact of a lifestyle weight loss intervention in a population of patients taking antidepressants and/or antipsychotic medication.
The FDA is warning consumers to stop using products known as Miracle or Master Mineral Solution, Miracle Mineral Supplement, MMS, Chlorine Dioxide Protocol, and Water Purification Solution due to numerous reports of significant health issues.
Higher affective well-being was associated not only with greater longevity but also with healthier aging without chronic disease or disability.
More than 90% of respondents indicated that the program met their learning needs and expectations.
A recently published systematic review investigated the benefits and risks of melatonin supplementation for pediatric patients with sleep disturbances.
The American Psychiatric Association’s president, Altha Stewart, MD, sat with Valerie Jarrett, JD, for a fireside chat focused on the Affordable Care Act.
